İstinye University Molecular Oncology Doctorate Program has been established to generate innovative solutions at the molecular level against cancer—one of the most complex health challenges of modern medicine—and to create scientific added value on a global scale. Our program is one of the leading academic initiatives in our country, synthesizing in-depth theoretical knowledge in cancer biology with advanced pharmacological research disciplines.
In alignment with the biotechnology vision of the 21st century, we focus on transforming data obtained through high-throughput technologies into tangible drug targets. Built upon nearly two decades of international academic experience, hundreds of distinguished publications, and thousands of citations, our program educates highly qualified scientists capable of analyzing cancer development, progression, and metastasis mechanisms at the cellular level.
Translational Medicine and Contribution to National Drug Policies:
A distinguishing feature of our doctoral program is its strategic bridging role between basic scientific research and clinical practice. With the support of our faculty members serving within the university hospital, we prioritize translational studies in which laboratory findings are transformed into clinical benefits.
Next-Generation Drug Discovery: The competence to lead pharmacodynamic, pharmacokinetic, and drug screening studies by transferring accumulated knowledge in cancer biology into advanced pharmacological research.
Multidisciplinary Research Culture: The capacity to develop holistic solutions to complex biological problems by integrating disciplines such as molecular biology, biochemistry, and medicinal chemistry.
Strategic Health Vision: The objective of educating distinguished academicians who can assume guiding roles in national drug and health policies, possess a strong academic vision, and contribute to universal science.
As İstinye University, our fundamental aim is to institutionalize the research–clinical interaction that remains underdeveloped in our country and to educate Doctors of Philosophy who will develop new treatment modalities in oncology and attain scientific authority on international platforms.